Karp and Gilliam Scrub Typhus Strains Rewire Macrophages in Different Ways
Scrub typhus is not a single immunologic script. In a new transcriptomic analysis of Orientia tsutsugamushi infection, Karp and Gilliam strains drove sharply different macrophage responses, offering a plausible explanation for why these clinically dominant lineages do not behave the same way in disease. The work centered on C57BL/6 mouse-derived macrophages and used RNA sequencing to map how the host cell programs shifted after infection.
The contrast was immediate at the pathway level. Both strains altered canonical immune programs, but Karp and Gilliam each left a distinct transcriptional footprint. Karp preferentially activated proinflammatory signaling and pattern-recognition machinery, while Gilliam pushed macrophages toward proliferation- and DNA replication-related programs. In a pathogen that survives inside host cells, those differences are not cosmetic; they shape whether the macrophage becomes an inflammatory amplifier or a permissive niche.
Karp’s inflammatory bias fits the disease pattern already seen in animal work, where Karp-infected mice develop more severe outcomes than Gilliam-infected counterparts. Excessive cytokine and chemokine production can be protective at first and destructive shortly after, especially when the response spills into tissue injury and vascular dysfunction. In scrub typhus, where endothelial involvement and multi-organ damage drive mortality, an overbuilt macrophage response can become part of the problem rather than the solution.
Innate Sensors Split Along Strain Lines
Among the strongest findings was the selective upregulation of pattern recognition receptors in Karp infection. The strain uniquely increased expression of C-type lectin receptors, including Mincle (Clec4e) and Dectin-2 (Clec4n). Those receptors matter because they sit at the intersection of microbial sensing and inflammatory amplification, translating pathogen encounter into intracellular signaling cascades that can intensify host defense and, in some settings, host injury.
This is a useful clue to the biology of scrub typhus. Unlike many bacteria, O. tsutsugamushi lacks lipopolysaccharide and has an unusual membrane structure, which likely forces the innate immune system to rely on alternative sensing pathways. Karp appears to engage those alternate receptors more aggressively, creating a stronger inflammatory signature inside macrophages. The result is a host cell that looks primed for a type 1-skewed response, with all the downstream consequences that can follow in infected tissues.
Gilliam traveled a different route. Instead of turning up the inflammatory dials, it enhanced macrophage proliferation and DNA replication signatures. In practical terms, that suggests a cellular environment that may be more permissive for intracellular bacterial expansion. The study also found that Gilliam grew better in M0-like macrophages than Karp did, reinforcing the idea that the basal, unpolarized macrophage state offers Gilliam a more favorable replication setting.
One sentence captures the divergence cleanly: Karp drives inflammation; Gilliam exploits cell growth.
Macrophage Polarization Changes the Balance of Survival
The data became even more interesting when macrophages were preconditioned with interferon-gamma. In IFNγ-primed, M1-like macrophages, Karp showed significantly greater resistance to host killing than Gilliam. That finding suggests a pathogen capable of surviving not only in a resting macrophage, but also in a cell state built to enhance microbial clearance.
This kind of resistance has direct mechanistic implications. IFNγ ordinarily strengthens antimicrobial effector functions, and M1 polarization should, in theory, tighten the intracellular environment against bacterial survival. Karp’s ability to withstand that pressure suggests strain-specific immune evasion, not just passive persistence. If a strain can endure a proinflammatory macrophage, it can continue to seed inflammation while escaping the very effector pathways meant to clear it.
Gilliam, by contrast, seemed less equipped to survive that activated environment. Its growth advantage in naïve macrophages did not translate into the same resilience when host killing was intensified. That difference may help explain why the two strains produce different disease phenotypes even though both belong to the same species and both infect the same key immune cell type.
Why the Pathway Differences Matter at the Bedside
Macrophages are not bystanders in scrub typhus. They are central to bacterial replication, immune coordination, and cytokine release, and they sit upstream of many of the tissue-level events that define severe disease. A strain that favors proinflammatory signaling can amplify vascular injury and organ dysfunction, while a strain that supports macrophage proliferation may prolong intracellular persistence with a different inflammatory profile. Those are two distinct routes to pathogenicity, and both are clinically relevant.
The study’s transcriptomic approach is valuable because it moves beyond broad labels like “more virulent” or “less virulent.” It shows which innate pathways are selectively engaged and which host programs are being co-opted. For clinicians and researchers working on scrub typhus, that distinction matters because it suggests different biomarkers may be needed to capture strain-specific severity, and different therapeutic strategies may be required to blunt the damage caused by each lineage.
The work also reinforces a broader principle in intracellular infection: host-pathogen interaction is not static. A bacterium that provokes strong inflammation in one macrophage state may survive better in another, and the balance between those states can shape outcome. In Karp infection, the host sees a strain that not only fires inflammatory receptors but also withstands IFNγ-mediated pressure. Gilliam behaves more like a strain adapted to replication in a permissive baseline environment.
Transcriptomic Clues Point to Strain-Specific Pathogenesis
These findings do not just add detail to an existing model; they sharpen it. Karp appears to be the more inflammatory strain, with selective activation of CLRs and a type 1-skewed immune profile that could help explain its association with more severe disease. Gilliam, meanwhile, appears better suited to growth in less activated macrophages, hinting at a replication strategy that depends more on cellular permissiveness than on provoking a strong inflammatory alarm.
Because the study used RNA-seq, it provides a high-resolution view of host response rather than a single cytokine snapshot. That approach makes it possible to see the architecture of the macrophage response: sensing, signaling, proliferation, and antimicrobial resistance. It also identifies candidate pathways that may be worth following in future mechanistic work, especially if investigators want to understand how innate immune recognition translates into strain-specific tissue injury.
The data leave one practical question open: which of these transcriptional signatures will prove most useful as biomarkers of severity in human scrub typhus. The current work does not answer that directly, but it gives a biologically coherent starting point. Karp’s preferential induction of inflammatory receptors and resistance to IFNγ-mediated killing make it a strong candidate for the more damaging host interaction, while Gilliam’s proliferative signature suggests a different route to persistence that may require separate therapeutic attention.